Comprehensive and Detailed Explanation:
Medication use during lactation should be evaluated through an individualized risk-benefit assessment. Most medications enter human milk to some degree, but many are compatible with breastfeeding because infant exposure is low and clinically insignificant. The benefits of continued breastfeeding often outweigh the potential risks associated with maternal medication use.
IBCLCs play an important role in helping families obtain evidence-based information from reliable lactation pharmacology resources. Factors influencing infant exposure include the drug’s molecular weight, protein binding, half-life, oral bioavailability, dosage, timing of administration, and the infant’s age and health status.
The assumption that all medications require breastfeeding cessation is incorrect and may unnecessarily disrupt breastfeeding. Likewise, routine pumping and discarding of milk is not indicated for most medications. Instead, each situation should be evaluated individually with consideration of maternal health needs and infant safety.
The IBCLC examination frequently emphasizes evidence-based counseling, encouraging healthcare professionals to balance medication risks with the significant nutritional, immunological, developmental, and psychological benefits of breastfeeding.